FDA clears Siemens’ high-sensitivity troponin diagnostic test for acute MI

Subrata Thakar | | Cardiovascular Business | Acute Coronary Syndromes
Siemens Healthineers

Siemens Healthineers received FDA approval of its High-Sensitivity Troponin I assays (TnIH)1 for the Atellica IM and ADVIA Centaur XP/XPT in vitro diagnostic analyzers. The new troponin assays will allow physicians to correctly diagnose patients for acute myocardial infarction (MI).

Compared to traditional assays, Siemens’ troponin assays are designed to detect lower levels of troponin proteins with 99 percent precision. They can also detect slighter changes in a patient’s troponin levels as repeat testing occurs.

The assays were approved for usage in Europe in May 2017 and meet the current European Society of Cardiology standards.

“This design affords clinicians greater confidence in the results with precision that provides the ability to measure slight, yet critical, changes to begin treatment,” Siemens noted in a prepared statement. “As science progresses, guidelines for determining high-sensitivity also evolves. These TnIH assays meet the latest industry guidelines.”

""
Subrata Thakar

As a senior news writer for TriMed, Subrata covers cardiology, clinical innovation and healthcare business. She has a master’s degree in communication management and 12 years of experience in journalism and public relations.

Related Content

Cardiologists reflect on developing primary PCI in face of criticism and pushback
IVUS-guided PCI reduces risks in patients with diabetes
Predicting sudden cardiac death after a heart attack may be impossible—for now
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT
FDA clears AI tool that flags signs of heart disease in chest CT scans

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."